Sunday, September 13, 2020

AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases (Leah Rosenbaum/Forbes)

Leah Rosenbaum / Forbes:
AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases  —  Startups that want to leverage artificial intelligence in drug discovery are a dime a dozen in today's biotech landscape.



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Alibaba says its Qwen AI models will be integrated into BYD, Volkswagen, and other cars, letting users buy food and tickets via voice commands on select models (Evelyn Cheng/CNBC)

Evelyn Cheng / CNBC : Alibaba says its Qwen AI models will be integrated into BYD, Volkswagen, and other cars, letting users buy food and...